ARTICLE | Company News
Neurochem other research news
January 31, 2000 8:00 AM UTC
Neurochem will receive up to C$7.9 million (US$5.5 million) over three years from Technology Partnerships Canada to develop Alzhemed to treat and prevent Alzheimer's disease. Technology Partnerships i...